Microcystins are toxins produced by many cyanobacteria species, which are often released into waterways during blue-green algal blooms in freshwater and marine habitats. The consumption of microcystin-contaminated water is a public health concern as these toxins are recognized tumor promoters and are hepatotoxic to humans and animals. A method to confirm human exposures to microcystins is needed; therefore, our laboratory has developed an immunocapture liquid chromatography tandem mass spectrometry (LC-MS/MS) method targeting the conserved adda portion of microcystins for the quantitation of a prevalent and highly toxic congener of microcystin, microcystin-LR (MC-LR). An acute exposure method was initially evaluated for accuracy and precision by analyzing calibrators and quality control (QC) samples ranging from 0.500 to 75.0 ng/mL in urine. All calibrators and QC samples characterized were within 15% of theoretical concentrations. An analysis of acutely exposed mouse urine samples using this method identified MC-LR levels from 10.7 to 33.9 ng/mL. Since human exposures are anticipated to result from low-dose or chronic exposures, a high-sensitivity method was validated with 20 calibration curves and QC samples ranging from 0.0100 to 7.50 ng/mL. Relative standard deviations (RSDs) and inaccuracies of these samples were within 15%, meeting United States Food and Drug Administration (FDA) guidelines for analytical methods, and the limit of detection was 0.00455 ng/mL. In conclusion, we have developed a method which can be used to address public health concerns by precisely and accurately measuring MC-LR in urine samples.

The majority of fatalities from poisonous mushroom ingestion are caused by amatoxins. To prevent liver failure or death, it is critical to accurately and rapidly diagnose amatoxin exposure. We have developed an liquid chromatography tandem mass spectrometry method to detect alpha-, beta-, and gamma-amanitin in urine to meet this need. Two internal standard candidates were evaluated, including an isotopically labeled (15)N10-alpha-amanitin and a modified amanitin methionine sulfoxide synthetic peptide. Using the (15)N10-alpha-amanitin internal standard, precision and accuracy of alpha-amanitin in pooled urine was </=5.49% and between 100 and 106%, respectively, with a reportable range from 1-200 ng/mL. beta- and gamma-Amanitin were most accurately quantitated in pooled urine using external calibration, resulting in precision </=17.2% and accuracy between 99 and 105% with calibration ranges from 2.5-200ng/mL and 1.0-200ng/mL, respectively. The presented urinary diagnostic test is the first method to use an isotopically labeled alpha-amanitin with the ability to detect and confirm human exposures to alpha-, beta-, and gamma-amanitin.